In view of previous research results we speculate that TYK2 can be used as a biomarker for HNSCC and may be involved in the immune infiltration of the HNSCC tumor microenvironment, in addition, TYK2 has an impact on the malignant biological characteristics of HNSCC cells. This evidence concerns the gene TYK2 and head and neck squamous cell carcinoma.